74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
English (International)
P Palvella Therapeutics Inc
P
Closed
SectorHealthcare
120.65 -11.43
Overview
Share price change
24h
Min
120.47
Max
125.3
Income | -1.9M -11M |
|---|---|
Employees | 14 |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +77.47% upside |
Next Earnings | 30 Mar 2026 |
|---|
Market Cap | 1.6B |
|---|---|
Previous open | 132.08 |
Previous close | 120.65 |
News Sentiment
By Acuity
100%
0%
335 / 351 Healthcare
Palvella Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Palvella Therapeutics Inc Forecast
Price Target
By TipRanks
77.47% upside
12 Months Forecast
Average 216.62 USD 77.47%
High 267 USD
Low 76.43 USD
Based on 12 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
335 / 351 Healthcare
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Pre-tax profit
Sales
Interest expense on debt
Operating profit
$
Live chat